Skip to main content

Advertisement

SpringerLink
Log in

Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to evaluate the efficacy of dual-phase 99mTc-methoxyisobutylnitrile (MIBI) parathyroid scintigraphy (PS) and ultrasound (US) in primary (pHPT) and secondary (sHPT) hyperparathyroidism.

Methods

A total of 69 patients (mean age 47 ± 16; age range 14–79 years), including 19 patients with sHPT were enrolled in this study. Preoperative serum intact parathyroid hormone (iPTH) levels, calcium (Ca), phosphate (P), alkaline phosphatase, and 24-h urinary-free Ca measurements were obtained. Concomitant thyroid pathology was also recorded.

Results

Histopathology revealed 30 solitary adenomas and 71 hyperplastic glands in 55 patients. The remaining patients’ histopathology revealed normal parathyroid, thyroid, or lymph nodes. The sensitivities of MIBI and US in pHPT were 70% and 60%, respectively. It was 60% for both procedures in sHPT. The overall sensitivity of combined US + MIBI in pHPT and sHPT was 81% and 71%, respectively. The overall specificity of MIBI and US was 87% and 91%; positive predictive value (PPV) was 94% and 92%, respectively. MIBI and US identified the parathyroid pathology in 92% and 85% of patients in the non-concomitant thyroid disease group, and in 53% and 47% of patients in the concomitant thyroid disease group, respectively. The weight of the gland between primary and secondary hyperparathyroidism did not reveal a significant difference (P = 0.4). Significant differences were found with respect to age, PTH, Ca, and P levels between the pHPT and sHPT (P < 0.001). Intact PTH levels showed significant differences between MIBI positive and negative patients (P = 0.013), and also US positive and negative patients (P = 0.012). A significant negative correlation was found between iPTH and Ca at sHPT (P < 0.001).

Conclusions

The concomitancy of thyroid disease greatly influences scintigraphic and ultrasonographic detection of parathyroid pathology in pHPT and sHPT. The combination of MIBI and US appears promising for localizing parathyroid pathology in patients with both primary and secondary hyperparathyroidism. The concordance rate is high together with a lower chance of missing concomitant thyroid pathology, which might alter the surgical approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343:1863–1875.

    Article  PubMed  CAS  Google Scholar 

  2. John T. Potts. Disease of the parathyroid gland and other hyper and hypocalcemic disorders. In: Harrison’s Principles of Internal Medicine, Braunwald E, Fauci AS, Kasper DL (eds), 15th ed. New York: McGrawhill; 2001. p. 2205–2226.

    Google Scholar 

  3. Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791–794.

    Article  PubMed  CAS  Google Scholar 

  4. Wei JP, Burke GJ, Mansberger AR Jr. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery 1992;112:1111–1116; discussion 1116-7.

    PubMed  CAS  Google Scholar 

  5. Pattou F, Oudar C, Huglo D, Racadot A, Carnaille B, Proye C, et al. Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrofosmine. J Surg 1998;68:108–111.

    CAS  Google Scholar 

  6. Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, et al. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with 99m Tc-MIBI, (201) Tl, MRI and US. Eur J Nucl Med 2001;28:1817–1827.

    Article  PubMed  CAS  Google Scholar 

  7. Crane P, Laliberte R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993;20:20–25.

    Article  PubMed  CAS  Google Scholar 

  8. Mitchell BK, Cornelius EA, Zoghbi S, Murren JR, Ghoussoub R, Flynn SD. Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein. Surgery 1996;120:1039–1045.

    Article  PubMed  CAS  Google Scholar 

  9. Neumann DR, Esselstyn CB Jr, Madera AM. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Am J Roentgenol 1997;169:1671–1674.

    CAS  Google Scholar 

  10. Lee VS, Spritzer CE, Coleman RE, Wilkinson RH Jr, Coogan AC, Leight GS Jr. The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands. Am J Roentgenol 1996;67:1555–1562.

    Google Scholar 

  11. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801–1807.

    PubMed  CAS  Google Scholar 

  12. Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Preoperative localization of parathyroid adenomas using 99mTc-MIBI scintigraphy. Am J Med 2000;108:733–736.

    Article  PubMed  CAS  Google Scholar 

  13. Kaczirek K, Prager G, Kienast O, Dobrozemsky G, Dudczak R, Niederle B, et al. Combined transmission and (99m) Tcsestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin 2003;42:220–223.

    PubMed  CAS  Google Scholar 

  14. Ishibashi M, Uchida M, Nishida H, Hiromatsu Y, Kohno K, Okuda S, et al. Presurgical localization of ectopic parathyroid glands using three-dimensional CT imaging, 99Tcm sestamibi, and 99Tcm tetrofosmin imaging. Br J Radiol 1999;72:296–300.

    PubMed  CAS  Google Scholar 

  15. Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. Comparison of technetium-99m MIBI, technetium-99m tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998;39:320–324.

    PubMed  CAS  Google Scholar 

  16. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005;35:266–276.

    Article  PubMed  Google Scholar 

  17. Lopez Hanninen E, Vogl TJ, Steinmuller T, Ricke J, Neuhaus P, Felix R. Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism. Invest Radiol 2000;35:426–430.

    Article  PubMed  CAS  Google Scholar 

  18. Mazzeo S, Caramella D, Lencioni R, Molea N, De Liperi A, Marcocci C, et al. Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. Am J Roentgenol 1996;166:1465–1470.

    CAS  Google Scholar 

  19. Mazzeo S, Caramella D, Marcocci C, Lonzi S, Cambi L, Miccoli P, et al. Contrast-enhanced color Doppler ultrasonography in suspected parathyroid lesions. Acta Radiol 2000;41:412–416.

    Article  PubMed  CAS  Google Scholar 

  20. Norman J, Cheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998–1003.

    Article  PubMed  CAS  Google Scholar 

  21. Wells SA Jr, Ellis GJ, Gunnells JC, Schneider AB, Sherwood LM. Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med 1976;295:57–62.

    Article  PubMed  Google Scholar 

  22. Rosai and Ackerman’s; Ackerman’s Surgical Pathology, Juan Rosai, Lauren V. Ackerman. 9th ed. Parathyroid glands. 9th ed. Philadelphia: Mosby; 2004. p. 597–601.

    Google Scholar 

  23. Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R. 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 2001;28:209–213.

    Article  PubMed  CAS  Google Scholar 

  24. Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998;39:1441–1444.

    PubMed  CAS  Google Scholar 

  25. Hajioff D, Iyngkaran T, Panagamuwa C, Hill D, Stearns MP. Preoperative localization of parathyroid adenoma: ultrasonography, sestamibi scintigraphy, or both? Clin Otolaryngology 2004:29:549–552.

    Article  CAS  Google Scholar 

  26. Gotthardt M, Lohmann B, Behr TM, Bauhofer A, Franzius C, Schipper ML, et al. Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 2004;28:100–107.

    Article  PubMed  Google Scholar 

  27. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands. Clin Endocrinol (Oxf) 2002;57:241–249.

    Article  Google Scholar 

  28. Barczynski M, Golkowski F, Konturek A, Buziak-Bereza M, Cichon, Hubalewska A, et al. Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas in directing surgical approach. Clin Endocrinol (Oxf) 2006;65:106–113.

    Article  Google Scholar 

  29. Mortier P-E, Mozzon MM, Fouquet OP, Soudan BC, Huglo DG, Cussac JF. Unilateral Surgery for Hyperparathyroidism: Indications, Limits, and Late Results-New Philosophy or Expensive Selection without Improvement of Surgical Results? World J Surg 2004;28:1298–1304.

    Article  PubMed  Google Scholar 

  30. Ambrosoni P, Heuguerot C, Olaizola I, Acuna G, Fajardo L, Petraglia A, et al. Can we use 99mTc-MIBI in functional studies of the parathyroid gland? Nephrol Dial Transplant 1998;13Suppl 3:33–36.

    Article  PubMed  Google Scholar 

  31. Hung GU, Wang SJ, Lin WY. Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism. Clin Nucl Med 2003;28:180–185.

    Article  PubMed  Google Scholar 

  32. Biertho LP, Kim C, Wu HS, Ungar P, Inabnet WB. Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg 2004;199:229–233.

    Article  PubMed  Google Scholar 

  33. Feinfeld DA, Sherwood LM. Parathyroid hormone and 1,25(OH) 2D3 in chronic renal failure. Kidney Int 1988;33:1049–1058.

    Article  PubMed  CAS  Google Scholar 

  34. Sekiyama K, Akakura K, Mikami K, Mizoguchi K, Tobe T, Nakano K, et al. Usefulness of diagnostic imaging in primary hyperparathyroidism. Int J Urol 2003;10:7–11; discussion 12.

    Article  PubMed  Google Scholar 

  35. Moka D, Eschner W, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas? Eur J Nucl Med 2000;27:485–489.

    Article  PubMed  CAS  Google Scholar 

  36. De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, et al. Parathyroid glands: Combination of (99m) Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000;214:393–402.

    PubMed  Google Scholar 

  37. Torregrosa JV, Fernandez-Cruz L, Canalejo A, Vidal S, Astudillo E, Almaden Y, et al. (99m)Tc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 2000;24:1386–1390.

    Article  PubMed  CAS  Google Scholar 

  38. Purcell GP, Dirbas FM, Jeffrey RB, Lane MJ, Desser T, McDougall IR, et al. Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi. Arch Surg 1999;134:824–828; discussion 828-30.

    Article  PubMed  CAS  Google Scholar 

  39. Lumachi F, Zucchetta P, Marzola MC, Boccagni P, Angelini F, Bui F, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 2000;143:755–760.

    Article  PubMed  CAS  Google Scholar 

  40. Prager G, Czerny C, Ofluoglu S, Kurtaran A, Passler C, Karzirek K, et al. Impact of localisation studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg 2003;196:541–548.

    Article  PubMed  Google Scholar 

  41. Rutledge R, Stiegel M, Thomas CG Jr, Wild RE. The relation of serum calcium and intact parathormone levels to parathyroid size and weight in primary hyperparathyroidism. Surgery 1985;98:1107–1112.

    PubMed  CAS  Google Scholar 

  42. Saxe AW, Lincenberg S, Hamburger SW. Can the volume of abnormal parathyroid tissue is predicted by preoperative biochemical measurement? Surgery 1987;102:840–845.

    PubMed  CAS  Google Scholar 

  43. Adalet I, Hawkins T, Clark F, Wilkonson R. 1994 Thallium-technetium-subtraction scintigraphy in secondary hyperparathyroidism. Eur J Nucl Med 1994;21:509–513.

    PubMed  CAS  Google Scholar 

  44. Piga M, Bolasco P, Satta L, Altieri P, Loi G, Nicolosi A, et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparao thyroidism. J Nucl Med 1996;37:565–569.

    PubMed  CAS  Google Scholar 

  45. Ryan JA, Eisemberg B, Pado KM and Lee. Efficacy of selective unilateral exploration in hyperparathyroidism based on localization tests. Arch Surg 1997;132:886–890.

    PubMed  Google Scholar 

  46. Taira N, Doihara H, Hara F, Shien T, Takabatake D, Takahashi H, et al. Less invasive surgery for primary hyperparathyroidism based on preoperative 99mTc-hexakis-2-methoxyisobutylisonitrile imaging fi ndings. Surg Today 2004;34:197–203.

    Article  PubMed  Google Scholar 

  47. Regal M, Paramo C, Luna Cano R, Perez Mendez LF, Sierra JM, Rodriguez I, et al. Coexistence of primary hyperparathyroidism and thyroid disease. J Endocrinol Invest 1999;22:191–197.

    PubMed  CAS  Google Scholar 

  48. dell’Erba L, Baldari S, Borsato N, Bruno G, Calo-Gabrieli G, Carletto M, et al. Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism. Eur J Endocrinol 2001;145:429–434.

    Article  PubMed  CAS  Google Scholar 

  49. Gofrit ON, Lebensart PD, Pikarsky A, Lackstein D, Gross DJ, Shiloni E. High-resolution ultrasonography: highly sensitive, specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease. World J Surg 1997;21:287–290; discussion 290-1.

    Article  PubMed  CAS  Google Scholar 

  50. Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S, et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997;24:143–149.

    Article  PubMed  CAS  Google Scholar 

  51. Masatsugu T, Yamashita H, Noguchi S, Nishii R, Watanabe S, Uchino S, et al. Significant clinical differences in primary hyperparathyroidism between patients with and those without concomitant thyroid disease. Surg Today 2005;35:351–356.

    Article  PubMed  Google Scholar 

  52. Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003;44:904–908.

    PubMed  Google Scholar 

  53. Nishiyama RH, Farhi D, Thompson NW. Radiation exposure and the simultaneous occurrence of primary hyperparathyroidism and thyroid nodules. Surg Clin North Am 1979;59:65–75.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Adana Teaching and Medical Research Center, Baskent University Faculty of Medicine, Dadaloglu Mah, 39 Sokak, No. 6, Yuregir, 01250, Adana, Turkey

    Aysun Sukan, Mehmet Reyhan, Mehmet Aydin, Ali F. Yapar & Ayse Aktas

  2. Department of Biostatistics, Cukurova University, Adana, Turkey

    Yasar Sert

  3. Department of Pathology, Baskent University Faculty of Medicine, Ankara, Turkey

    Tuba Canpolat

Authors
  1. Aysun Sukan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Reyhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehmet Aydin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ali F. Yapar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasar Sert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tuba Canpolat
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ayse Aktas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aysun Sukan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sukan, A., Reyhan, M., Aydin, M. et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med 22, 123–131 (2008). https://doi.org/10.1007/s12149-007-0086-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-007-0086-z

Keywords

Search

Navigation